← Back to Search

video-thorascopy + surgery for Lung Cancer

N/A
Waitlist Available
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

RATIONALE: Diagnostic procedures such as thoracoscopy may help to measure a patient's response to previous treatment. PURPOSE: Diagnostic trial to determine the accuracy of thoracoscopy in patients who have stage IIIA non-small cell lung cancer.

Eligible Conditions
  • Lung Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

1Treatment groups
Experimental Treatment
Group I: video-thorascopy + surgeryExperimental Treatment1 Intervention
Patients will undergo ipsilateral video-thorascopic evaluation. Patients may undergo surgery at the discretion of the surgeon and treating physicians.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
videothoracoscopy
2004
N/A
~110

Find a Location

Who is running the clinical trial?

Alliance for Clinical Trials in OncologyLead Sponsor
513 Previous Clinical Trials
218,227 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,872 Previous Clinical Trials
41,010,702 Total Patients Enrolled
Michael Jaklitsch, MDStudy ChairDana-Farber/Brigham and Women's Cancer Center
~3 spots leftby Oct 2025